Literature DB >> 2567122

Changing patterns of neuroleptic dosage over a decade.

G T Reardon1, A Rifkin, A Schwartz, A Myerson, S G Siris.   

Abstract

A study of patterns of neuroleptic dosage for 206 schizophrenic inpatients showed significant differences over time and among three centers--a general hospital psychiatric unit, a community mental health center, and a state hospital. In 1982 patients' mean dose at discharge was higher than the peak mean daily dose in 1973, and high-potency neuroleptics were being used almost exclusively. The mean length of stay decreased from 49 days in 1973 to 34 days in 1982. The possible relationship, if any, between increasing dosage, decreased length of stay, and the switch from low-potency to high-potency neuroleptics remains undetermined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567122     DOI: 10.1176/ajp.146.6.726

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.

Authors:  R A Kiivet; A Llerena; M L Dahl; L Rootslane; J Sánchez Vega; T Eklundh; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

Review 2.  Review: treatment of schizophrenia. State of the art.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

3.  Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment.

Authors:  Joo Yeon Jeong; Haangik Park; Hong Yoo; Eun-Jin Kim; Borami Jeon; Jong Deog Lee; Dawon Kang; Changjoon Justin Lee; Sun Ha Paek; Eun Joo Roh; Gwan-Su Yi; Sang Soo Kang
Journal:  Biomedicines       Date:  2022-04-30

4.  Neuroleptic medication and prescription practices with sheltered-care residents: a 12-year perspective.

Authors:  S P Segal; D Cohen; S R Marder
Journal:  Am J Public Health       Date:  1992-06       Impact factor: 9.308

Review 5.  Trifluoperazine for schizophrenia.

Authors:  L O Marques; M S Lima; B G O Soares
Journal:  Cochrane Database Syst Rev       Date:  2004
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.